Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events patient preferences considered first time fda decision approve first kind obesity
… face the common challenge of predicting long-term patient-relevant outcomes from short-term clinical trial … clinical trial data for a treatment for early AD. We first compared the groups’ modeling approaches to understand … Based on our analysis, we recommend that modelers and decision makers consider sensitivity analyses that explicitly …
… to initial stimulant treatment and consequently might be considered for treatment with one of two second-line … had an inadequate response to the currently recommended first-line stimulant treatment. The study, titled A …
… regulatory negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide … and support measurement strategies acceptable to the FDA following the release of the FDA’s PRO Guidance. To support these efforts, we have …
… said Dr. Goyal. Dr. Goyal’s dissertation represents the first population-based observational study in the United … breast cancer. The research also identified several patient-level factors and social determinants of health as … novel evidence to all stakeholders involved in healthcare decision-making for patients with HR+/HER2– metastatic breast …
… New Patient-Reported Outcomes Diary for Rare Acromegaly Disorder … and treatment outcomes associated with their condition. First-hand experiences with the symptoms, treatment outcomes, … drug development. The US Food and Drug Administration (FDA) strongly encourages the use of PROs in clinical trials …
… RTI-HS Researchers Outline Best Practices for Collecting Patient Experience Data During the COVID-19 Outbreak Share … April 9, 2020 Updated November 10, 2020 Experts on our Patient-Centered Outcomes Assessment (PCOA) team collaborated … outcome assessment (COA) data. They drew on current FDA recommendations for patient-focused drug development …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …
… most. Researchers with RTI Health Solutions conducted a patient-preference study using a discrete-choice experiment … The primary objectives were to quantify patient preferences for PD OFF‑episode treatment features and … of administration along with the level of adverse effects Time to full "ON" (the time it would take to relieve …
… if they are going to provide reliable data. It is considered best practice to include some comprehension …
… FDA’s Sentinel Initiative Driving Sound Research Practices … on: November 11, 2021 RTI-HS is collaborating with the FDA to ensure that rigorous, valid methods are used to … RTI-HS, shares, “We are honored to be working with the FDA and their network of research collaborators committed to …